Drug Monograph
Hepatitis B vaccine (recombinant) 10mcg/mL; susp for IM inj; aluminum hydroxide adsorbed; preservative-free.
Select the therapeutic use below to view the corresponding drug monograph
Visit the related Resource Center for drug monographs, news, CME and other clinical tools for this drugs’ particular therapeutic area.
Drug Monograph
Hepatitis B vaccine (recombinant) 20mcg/mL; aluminum hydroxide adsorbed; IM inj; preservative-free; contains thimerosal (trace).
Select the therapeutic use below to view the corresponding drug monograph
Visit the related Resource Center for drug monographs, news, CME and other clinical tools for this drugs’ particular therapeutic area.
Drug Monograph
Hepatitis B vaccine (recombinant) 10mcg/0.5mL; aluminum hydroxide adsorbed; IM inj; preservative-free; contains thimerosal (trace).
Select the therapeutic use below to view the corresponding drug monograph
Visit the related Resource Center for drug monographs, news, CME and other clinical tools for this drugs’ particular therapeutic area.
Drug Monograph
Hepatitis B vaccine (recombinant), adjuvanted (formulated to contain HBsAg 20mcg + CpG 1018 3000mcg) per 0.5mL dose; soln for IM inj; preservative-free.
Select the therapeutic use below to view the corresponding drug monograph
Visit the related Resource Center for drug monographs, news, CME and other clinical tools for this drugs’ particular therapeutic area.
Drug Monograph
Diphtheria and tetanus toxoids, acellular pertussis vaccine, aluminum hydroxide adsorbed; hepatitis B vaccine (recombinant), aluminum phosphate adsorbed; inactivated polio vaccine; susp for IM inj; preservative-free; contains traces of formaldehyde, yeast protein, neomycin, polymyxin B, polysorbate 80.
Select the therapeutic use below to view the corresponding drug monograph
Visit the related Resource Center for drug monographs, news, CME and other clinical tools for this drugs’ particular therapeutic area.
Drug Monograph
Diphtheria and tetanus toxoids + acellular pertussis + inactivated poliovirus + Haemophilus b conjugate + hepatitis B vaccine; per 0.5mL; susp for IM inj; preservative-free; contains aluminum, polysorbate 80, and residual amounts of formaldehyde, glutaraldehyde, bovine serum albumin, yeast protein, neomycin, streptomycin, polymyxin B, ammonium thiocyanate.
Select the therapeutic use below to view the corresponding drug monograph
Visit the related Resource Center for drug monographs, news, CME and other clinical tools for this drugs’ particular therapeutic area.
Drug Monograph
Hepatitis B surface antigen vaccine (recombinant) 10mcg/mL; susp for IM inj; aluminum hydroxide adsorbed; preservative-free.
Select the therapeutic use below to view the corresponding drug monograph
Visit the related Resource Center for drug monographs, news, CME and other clinical tools for this drugs’ particular therapeutic area.
Drug Monograph
Hepatitis B surface antigen vaccine (recombinant) 40mcg/mL; susp for IM inj; aluminum hydroxide adsorbed; preservative-free.
Select the therapeutic use below to view the corresponding drug monograph
Visit the related Resource Center for drug monographs, news, CME and other clinical tools for this drugs’ particular therapeutic area.
Drug Monograph
Hepatitis B surface antigen vaccine (recombinant) 5mcg/0.5mL; susp for IM inj; aluminum hydroxide adsorbed; preservative-free.
Select the therapeutic use below to view the corresponding drug monograph
Visit the related Resource Center for drug monographs, news, CME and other clinical tools for this drugs’ particular therapeutic area.
News
Vaccination against human papillomavirus (HPV) in young males and hepatitis B in adults with diabetes mellitus is recommended by the Advisory Committee on Immunization Practices (ACIP) for infection control.